Long‐term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population‐based cohort study
Summary Background The long‐term effects of H. pylori eradication in preventing upper GI bleeding (UGIB) remains unknown. Aim To determine the long‐term risks of UGIB after H. pylori eradication Methods We included all patients who had received clarithromycin‐containing triple therapy for the treatm...
Saved in:
Published in | Alimentary pharmacology & therapeutics Vol. 54; no. 9; pp. 1162 - 1169 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.11.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0269-2813 1365-2036 1365-2036 |
DOI | 10.1111/apt.16604 |
Cover
Summary: | Summary
Background
The long‐term effects of H. pylori eradication in preventing upper GI bleeding (UGIB) remains unknown.
Aim
To determine the long‐term risks of UGIB after H. pylori eradication
Methods
We included all patients who had received clarithromycin‐containing triple therapy for the treatment of H. pyliori infection between 2003 and 2012, without subsequent need for re‐treatment. We included a propensity score (PS)‐matched endoscopy cohort of H. pylori‐negative patients as controls. The primary endpoint was the risk of subsequent UGIB. A multivariable Cox model was used to compute the hazard ratio (HR) of UGIB.
Results
We included 62 738 H. pylori‐eradicated and 62 738 PS‐matched H. pylori‐negative patients, with a median follow‐up of 8.1 years (IQR 5.5‐10.6). The incidence of UGIB was 20.8 (95% CI 19.5‐22.1) and 13.6 (95% CI 12.7‐14.7) per 10 000 person‐years in H. pylori‐eradicated and H. pylori‐negative patients, respectively. Compared to controls, H. pylori‐eradicated patients had a significantly higher risk of UGIB (HR: 1.65, 95% CI 1.49‐1.83). The risk of UGIB in H. pylori‐eradicated patients increased after the first 2 years of follow up (HR: 2.18, 95% CI 1.91‐2.49). Age‐stratified analysis showed that patients >45 years had higher UGIB risk, even after eradication.
Conclusions
Despite H. pylori eradication, the long‐term risk of UGIB was still higher than in H. pylori‐negative control subjects. The protective effects of eradication therapy in preventing UGIB appeared to be limited to younger patients, and to within the first 2 years after eradication.
Despite H. pylori eradication, the long‐term risk of UGIB was still higher than H. pylori‐negative subjects. The protective effects of H. pylori eradication in preventing UGIB appeared to belimited to within the first 2 years after eradication. |
---|---|
Bibliography: | The Handling Editor for this article was Dr Colin Howden, and it was accepted for publication after full peer‐review. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0269-2813 1365-2036 1365-2036 |
DOI: | 10.1111/apt.16604 |